Purchase Order 75N92E24P00192

<p>The National Human Genome Research Institute awarded a purchase order to Eurofins Genomics LLC for $14,975.00 on December 13, 2016, with a firm fixed price for research studies. Place of performance is Bethesda, Maryland. The order was not set-aside and carries an ultimate completion date of January 11, 2021.</p>

<p>The National Human Genome Research Institute issued a purchase order to the Trustees of the University of Pennsylvania on June 28, 2016, with a ceiling value of $4,129.20 and firm fixed pricing. Place of performance is Bethesda, Maryland. The order was completed by December 21, 2020. No set-aside designation was used.</p>

<p>This is a firm fixed price purchase order contract awarded by the National Human Genome Research Institute (NHGRI), a civilian agency, to Invivogen, a for-profit organization, for the delivery of biological and reagent materials. The contract has a ceiling value of $12,992.70 and a period of performance ending on March 3, 2026. This contract is not associated with a larger vehicle and does not have a set-aside designation. The NHGRI is the funding agency for this contract.</p>

The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a $15,613.88 firm fixed price delivery order to Illumina, Inc. under contract number QTE# 00015178.1. The place of performance will be Illumina's facilities located in San Diego, California. The period of performance is July 31, 2023 for genomic sequencing and analysis services to support the Institute's research efforts aimed at advancing the understanding of the human...

The Department of Health and Human Services' National Institutes of Health National Human Genome Research Institute awarded a $24,264 purchase order to Oxford Nanopore Technologies Inc. for the delivery of unspecified products or services. Performance will take place in New York, NY under a firm fixed price arrangement concluding on September 29, 2023. As the NIH/NHGRI supports genomic research to analyze DNA and interpret the book of life, this contract is likely to provide Oxford Nanopore's...

<p>The National Human Genome Research Institute issued a delivery order to Illumina, Inc. on March 27, 2018, with a ceiling value of $19,253.76 for genetic sequencing and genomic analysis technologies.</p> <p>Place of performance is Bethesda, MD. The order has a firm fixed price and was not issued under a set-aside. Ultimate completion date is September 2, 2020.</p>

<p>The National Human Genome Research Institute issued a purchase order to Peprotech Inc. for $2,250.00 in biological products on November 20, 2015, with completion scheduled for December 22, 2020. Work is performed in Washington, DC. The order is priced on a firm fixed-price basis with no set-aside designation.</p>

<p>The National Human Genome Research Institute issued a $122,145.01 delivery order to Illumina, Inc. on September 15, 2017, for genetic sequencing and genomic analysis technologies.</p> <p>Place of performance is Bethesda, MD 20892. The order has a firm fixed-price structure with an ultimate completion date of December 15, 2017. No set-aside was used.</p>

<p>The National Human Genome Research Institute issued a purchase order to Omega Bio-Tek, Inc. for $11,395.00 on July 15, 2016, with firm fixed pricing and a completion date of December 21, 2020. Place of performance is Bethesda, Maryland. No set-aside applied. The source does not specify the goods or services procured.</p>

This is a firm fixed-price delivery order contract awarded by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH), to The Johns Hopkins University, a private nonprofit research institution. The $182,700 contract is for high-throughput genotyping and whole genome sequencing (30X) services to support NHGRI's research into the genetic contributions to human health and disease. The contract has a period of performance ending on September 8,...